Diebold Nixdorf, Incorporated
DBD
$61.96
$0.210.34%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -3.75% | -2.66% | -0.25% | 2.88% | 7.19% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -3.75% | -2.66% | -0.25% | 2.88% | 7.19% |
| Cost of Revenue | -5.86% | -4.98% | -2.81% | 1.51% | 7.68% |
| Gross Profit | 3.04% | 4.91% | 8.17% | 7.34% | 5.63% |
| SG&A Expenses | 2.40% | -5.72% | -9.50% | -13.36% | -16.37% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -1,200.00% | -381.25% | -246.15% | -- | -- |
| Total Operating Expenses | -4.50% | -5.21% | -4.24% | -1.65% | 2.35% |
| Operating Income | 6.58% | 44.26% | 95.87% | 151.83% | 203.03% |
| Income Before Tax | -98.77% | -96.25% | -96.57% | -95.47% | 336.68% |
| Income Tax Expenses | -64.91% | 26.60% | -15.06% | -46.65% | 256.25% |
| Earnings from Continuing Operations | -100.47% | -100.54% | -101.05% | -99.83% | 318.50% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -75.00% | -46.67% | -300.00% | -162.07% | -139.02% |
| Net Income | -100.60% | -100.69% | -101.20% | -99.98% | 319.24% |
| EBIT | 6.58% | 44.26% | 95.87% | 151.83% | 203.03% |
| EBITDA | 3.91% | 26.88% | 55.72% | 74.31% | 102.95% |
| EPS Basic | -100.89% | -100.92% | -101.55% | -99.98% | 408.59% |
| Normalized Basic EPS | 12.34% | 326.37% | 1,009.73% | 335.71% | 268.57% |
| EPS Diluted | -100.91% | -100.95% | -101.59% | -100.00% | 405.21% |
| Normalized Diluted EPS | 12.19% | 325.08% | 1,012.54% | 335.73% | 268.45% |
| Average Basic Shares Outstanding | -11.64% | -29.11% | -40.75% | -49.08% | -46.53% |
| Average Diluted Shares Outstanding | -11.85% | -29.27% | -40.86% | -49.15% | -46.30% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |